An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

Autor: Van Cutsem, E. *, Siena, S., Humblet, Y., Canon, J.-L., Maurel, J., Bajetta, E., Neyns, B., Kotasek, D., Santoro, A., Scheithauer, W., Spadafora, S., Amado, R.G., Hogan, N., Peeters, M.
Zdroj: In Annals of Oncology January 2008 19(1):92-98
Databáze: ScienceDirect